Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -87.20% is 99% above its 5-year average of -17191.86%, near the high end of its 5-year range (-184854.47%–0.00%).
99.86% above its 12-month average of -61803.49%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2026-03-31): -550.53%.
NET PROFIT MARGIN
-87.20%
NET PROFIT MARGIN AVG TTM
-61803.49%
NET PROFIT MARGIN AVG 3Y
-26982.51%
NET PROFIT MARGIN AVG 5Y
-17191.86%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+99.86%
CURRENT VS 3Y AVG
+99.68%
CURRENT VS 5Y AVG
+99.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-33438.46%
vs the sector median at left
Paranovus Entertainment Technology Ltd.
Market Cap
$3.32M
Net Profit Margin
-87.20%
TTM Avg
-61803.49%
3Y Avg
-26982.51%
5Y Avg
-17191.86%
Market Cap
$3.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-523.72%
5Y Avg
-1138.73%
Market Cap
$3.15M
Net Profit Margin
-427.67%
TTM Avg
-455.53%
3Y Avg
-478.79%
5Y Avg
-375.12%
Market Cap
$3.49M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.49M
Net Profit Margin
-105.71%
TTM Avg
-81.70%
3Y Avg
-1471.40%
5Y Avg
-1177.12%
Market Cap
$3.12M
Net Profit Margin
-3089.55%
TTM Avg
-3099.32%
3Y Avg
-6095.20%
5Y Avg
-22555.36%
Market Cap
$3.49M
Net Profit Margin
-4139.38%
TTM Avg
-3617.24%
3Y Avg
-2890.13%
5Y Avg
-2863.43%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.32M | -87.20% | -61803.49% | -26982.51% | -17191.86% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.24M | 0.00% | 0.00% | -523.72% | -1138.73% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.15M | -427.67% | -455.53% | -478.79% | -375.12% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.49M | -105.71% | -81.70% | -1471.40% | -1177.12% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.12M | -3089.55% | -3099.32% | -6095.20% | -22555.36% |
| Eocene Ltd. (EOCN)vs › | $3.55M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | -4139.38% | -3617.24% | -2890.13% | -2863.43% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.64M | -10.89% | -10.89% | -13.47% | -4.61% |
Operating Margin
-23.1%
Net Profit Margin
-87.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -550.53% |
| 2025-09-30 | -5.49% |
| 2025-03-31 | -184854.47% |
| 2024-09-30 | -2655.39% |
| 2024-03-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-03-31 | -811.69% |
| 2022-09-30 | -114.75% |
| 2022-03-31 | -91.86% |
| 2021-09-30 | -21.45% |
| 2021-03-31 | -4.83% |
| 2020-09-30 | 14.56% |
| 2020-03-31 | 12.65% |
| 2019-09-30 | 26.86% |
| 2019-03-31 | 30.51% |
| 2018-09-30 | 28.01% |
| 2018-03-31 | 27.44% |
| 2017-09-30 | 29.57% |
